BeStock  
Markets › Compare › RIGL vs ANRO

RIGL vs ANRO

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
RIGL · Rigel Pharmaceuticals$47.99 ▲ 4.08%
ANRO · Alto Neuroscience$23.52 ▼ 0.72%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

58204349494640Oct 9, '25Apr 9, '26Oct 7, '26
  • RIGL +69.0%
  • ANRO +290.7%

Head to head

MetricRIGLANRO
Price$47.99$23.52
Change today▲ 4.08%▼ 0.72%
Market cap$896.45M$922.97M
Return, 3 months+9.7%-14.9%
Return, year to date+12.0%+32.1%
Return, 1 year+66.9%+278.7%
P/E (TTM)2.8-10.1
P/B2.14.2
P/E percentile vs own 5y73rd20th
Dividend yield––
Revenue growth (YoY, latest qtr)-22.6%–
Net profit growth (YoY)-71.0%-56.1%
Gross margin91.4%–
Operating margin31.5%–
Net margin116.3%–
Return on equity126.9%-49.2%
Analyst target vs. price+35.4%+87.1%
Analyst buy share50%100%
RSI (14)5522
30-day volatility34.0%47.6%
Max drawdown, 1 year-50.1%-35.8%
Trend readStrong uptrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ANRO is the largest of the group by market value.
  • ANRO has returned the most over the past year.
  • ANRO carries the lowest trailing P/E.
  • RIGL has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top